CDT Equity CDT
NASDAQ CDT
$1.27 -0.09 (-6.85%)
As of: Oct 1, 2026 · 3:57 PM EDT

CDT Equity (CDT) Non Operating Interest Expenses (2023 - 2024)

Updated

CDT Equity (CDT) posted Non Operating Interest Expenses of $309,000 for Q3 2024, up 557.4% from $47,000 a year earlier and up 159.7% from the prior quarter.

Analysis

CDT Equity (CDT) Non Operating Interest Expenses (2023 - 2024) Analysis & Trends

For the trailing twelve months through Sep 30, 2024, Non Operating Interest Expenses at CDT Equity was $594,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 CDT Equity 34,330.48 34,330.48 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 309,000.00
Jun 30, 2024 119,000.00
Mar 31, 2024 119,000.00
Sep 30, 2023 47,000.00
API Access

CDT Equity Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CDT&period=max&api_key=YOUR_API_KEY